Katie Wright, Author at European Medical Journal - Page 41 of 45

Restaging MRI Helps Predict Outcomes in Rectal Cancer Treatment

A new study highlights the crucial role of MRI in predicting key oncologic outcomes, such as organ preservation and survival

Does AI Improve Diagnostic Accuracy of Intracranial Haemorrhage?

A new study has shown that AI assistance did not significantly enhance radiologists’ diagnostic accuracy or reduce report turnaround times.

The AORTA Gene Score: A More Accurate Estimation of Aortic Dilation

Integrating a polygenic score with clinical data improves predicting ascending aortic diameter and thoracic aortic events, outperforming traditional models.

Rising Cancer Rates in Young Generations

A recent study examining cancer incidence trends among adults born between 1920 and 1990, revealed a concerning increase in cancer rates among younger generations.

Cardiovascular Risks Associated with Insomnia Medication

Benzodiazepine usage has been associated with increased risk of coronary heart diseases heart failure, and cardiovascular death, according to recent research.

Chemotherapy-Induced Gut Microbiome Changes Linked to Cognitive Decline

A new study found a significant link between chemotherapy-induced disruptions in the gut microbiome and cognitive decline in female patients with breast cancer.

Rising Infections in Hospitalised Children with Lupus

A new study brought to light significant risks associated with infections in children and adolescents with childhood-onset systemic lupus erythematosus.

joint pain from gout

Light Alcohol Cuts Gout Risk in Women, But Increases in Men

A RECENT study has found a link between alcohol consumption and the risk of developing gout.

The Link Between Graft Patency and Chronic Total Occlusion Failure

A multicentre study of 259 patients with prior CABG surgery found that post-PCI graft patency significantly predicts chronic total occlusion failure after PCI.

Assessing Risk of Anthracycline Cardiotoxicity Using The HFA-ICOS Score

A new score to assess the risk of anthracycline-induced cardiovascular toxicity has been developed by researchers.